Breaking Down Barriers In Immune-Excluded Tumor Biology
Time: 4:15 pm
day: Day Two
Details:
- Immune exclusion in tumors has been associated with unfavorable clinical outcome and poor response to therapy
- Therapies targeting immune exclusion are orthogonal to cancer immunotherapy and could improve responses
- DDR1 as an example of a druggable target implicated in establishing mechanical barriers for an immune response
